Inhibitory effects of trehalose on fibroblast proliferation and implications for ocular surgery

Experimental Eye Research

Volumn 91, Issue 5, 2010, Pages 567-577

  Takeuchi, Kimio ^a   Nakazawa, Mitsuru ^a   Ebina, Yuichi ^a   Sato, Kota ^a   Metoki, Tomomi ^a   Miyagawa, Yasuhiro ^a   Ito, Tadashi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Conjunctiva; Fibroblast; Glaucoma; Scar; Surgery; Trabeculectomy; Trehalose

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ISOLECTIN B4; MITOMYCIN C; TREHALOSE; VIMENTIN; ACTIN; ALPHA SMA PROTEIN, HUMAN; ALPHA-SMA PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONJUNCTIVA; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; EYE INJURY; EYE SURGERY; GLAUCOMA SURGERY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; KERATINOCYTE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLERA; SKIN FIBROBLAST; STAINING; SURGICAL WOUND; TRABECULECTOMY; VASCULAR TISSUE; WESTERN BLOTTING; ANIMAL; APOPTOSIS; CYTOLOGY; DERMIS; DRUG EFFECT; EPIDERMIS; FIBROBLAST; FIBROSIS; FLOW CYTOMETRY; METABOLISM; NICK END LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; POSTOPERATIVE COMPLICATION; RABBIT; SCAR;

ACTINS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CICATRIX; DERMIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPIDERMIS; FIBROBLASTS; FIBROSIS; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; KERATINOCYTES; POSTOPERATIVE COMPLICATIONS; RABBITS; TRABECULECTOMY; TREHALOSE; VIMENTIN;

EID: 78049513566     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.07.002     Document Type: Article

References (37)

1. Abe R., Donnelly S.C., Peng T., Bucala R., Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 2001, 166:7556-7562.
2. Abu EI-Asrar A.M., Al-Mannsouri S., Tabbara K.F., Missotten L., Geboes K. Immunopathogenesis of conjunctival remodeling in vernal keratoconjunctivitis. Eye 2008, 20:71-79.
3. Banerjee S., Savant V., Scott R.A., Curnow S.J., Wallace G.R., Murray P.I. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest. Ophthalmol. Vis. Sci. 2007, 48:2203-2207.
4. Belyea D.A., Dan J.A., Stamper R.L., Lieberman M.F., Spencer W.H. Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C. Am. J. Ophthalmol. 1997, 124:40-45.
5. Bruno C., Fisher G., Moroi S. Is " scarless wound healing" applicable to glaucoma surgery?. Expert. Rev. Ophthalmol. 2007, 2:79-90.
6. CAT-152 0102 Trabeculectomy Study Group, Khaw P., Grehn F., Holló G., Overton B., Wilson R., Vogel R., Smith Z. A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 2007, 114:1822-1830.
7. CAT-152 Trabeculectomy Study Group, Grehn F., Holló G., Khaw P., Overton B., Wilson R., Vogel R., Smith Z. Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152. Ophthalmology 2007, 114:1831-1838.
8. Crowe J.H., Hoekstra F.A., Crowe L.M. Anhydrobiosis. Annu. Rev. Physiol. 1992, 54:579-599.
9. DeBry P.W., Perkins T.W., Heatley G., Kaufman P., Brumback L.C. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch. Ophthalmol. 2002, 120:297-300.
10. Elner V.M., Newman-Casey P.A., Patil A.J., Flint A., Biswas J., Moroi S.E., Pushparaj V., Edward D.P. Aberrant wound-healing response in mitomycin C-treated leaking blebs. Arch. Ophthalmol. 2009, 127:1036-1042.
11. Freedman J. TGF-beta(2) antibody in trabeculectomy. Ophthalmology 2009, 116:166.
12. Greenfield D.S., Parrish R.K. Bleb rupture following filtering surgery with mitomycin C. Ophthalmic Surg. Lasers 1996, 27:876-877.
13. Guo N., Puhlev I., Brown D.R., Mansbridge J., Levine F. Trehalose expression confers desiccation tolerance on human cells. Nat. Biotechnol. 2000, 18:168-171.
14. Hashida N., Ohguro N., Nakai K., Kobayashi-Hashida M., Hashimoto S., Matsushima K., Tano Y. Microarray analysis of cytokines and chemokine gene expression after prednisolone treatment in murine experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci. 2005, 46:4224-4234.
15. Honjo M., Tanihara H., Kameda T., Kawaji T., Yoshimura N., Araie M. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery. Invest. Ophthalmol. Vis. Sci. 2007, 48:5549-5557.
16. Kitazawa Y., Kawase K., Matsushita H., Minobe M. Trabeculectomy with mitomycin. Arch. Ophthalmol. 1991, 109:1693-1698.
17. Kitazawa Y., Suemori-Matsushita H., Yamamoto T., Kawase K. Low-dose and high dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology 1993, 100:1624-1628.
18. Lee K.S., Park S.J., Kim S.R., Min K.H., Lee K.Y., Choe Y.H., Hong S.H., Lee Y.R., Kim J.S., Hong S.J., Lee Y.C. Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signaling pathway. Eur. Resp. J. 2008, 31:523-531.
19. Leslie S.B., Israeli E., Lighthart B., Crowe J.H., Crowe L.M. Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying. Appl. Environ. Microbiol. 1995, 61:3592-3597.
20. Li R., Maminishkis A., Wang F.E., Miller S.S. PDGF-C and -D induced proliferation/migration of human RPE is abolished by inflammatory cytokines. Invest. Ophthalmol. Vis. Sci. 2007, 48:5722-5732.
21. Matsuo T., Tsuchida Y., Morimoto N. Trehalose eye drops in the treatment of dry eye syndrome. Ophthalmology 2002, 109:2024-2029.
22. Matsuo T. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye. Jpn. J. Ophthalmol. 2004, 48:321-327.
23. Mayer R.J., Candy D.J. Changes in energy reserves during flight of the desert locust, Schistocerca gregaria. Comp. Biochem. Physiol. 1969, 31:409-418.
24. Mietz H., Arnold G., Kirchhof B., Diestelhorst M., Krieglstein G.K. Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C. Graefes Arch. Clin. Exp. Ophthalmol. 1996, 234:364-368.
25. Mori L., Bellini A., Stacey M.A., Schmidt M., Mattoli S. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp. Cell Res. 2005, 304:81-90.
26. Nakamura T., Sekiyama E., Takaoka M., Bentley A.J., Yokoi N., Fullwood N.J., Kinoshita S. The use of trehalose-treated freeze-dried amniotic membrane for ocular surface reconstruction. Biomaterials 2008, 29:3729-3737.
27. Nakamura H., Siddiqui S.S., Shen X., Malik A.B., Pulido J.S., Kumar N.M., Yue B.Y. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Mol. Vis. 2004, 10:703-711.
28. Ooi K.G.-J., Galatowicz G., Calder V.L., Lightman S.L. Cytokines and chemokines in uveitis - is there a correlation with clinical phenotypes?. Clin. Med. Res. 2006, 4:294-309.
29. Poulsen E.J., Allingham R.R. Characteristics and risk factors of infections after glaucoma filtering surgery. J. Glaucoma 2000, 9:438-443.
30. Sihota R., Dada T., Gupta S.D., Sharma S., Arora R., Agarwal H.C. Conjunctival dysfunction and mitomycin C-induced hypotony. J. Glaucoma 2000, 9:392-397.
31. Singer A.J., Clark R.A. Cutaneous wound healing. N. Engl. J. Med. 1999, 341:738-748.
32. Skuta G.L., Parrish R.K. Wound healing in glaucoma filtering surgery. Surv. Ophthalmol. 1987, 32:149-170.
33. Solomon A., Ticho U., Frucht-Pery J. Late onset, bleb associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents. J. Ocul. Pharmacol. Ther. 1999, 15:283-293.
34. Takeuchi K., Nakazawa M., Yamazaki H., Miyagawa Y., Ito T., Ishikawa F., Metoki T. Solid hyaluronic acid film and the prevention of postoperative fibrous scar formation in experimental animal eyes. Arch. Ophthalmol. 2009, 127:460-464.
35. Tanaka M., Machida Y., Niu S., Ikeda T., Jana N.R., Doi H., Kurosawa M., Nekooki M., Nukina N. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med. 2004, 10:148-154.
36. Tsurumaru N., Arai M., Teruya K., Sueda J., Yamakawa R. Seprafilm as a new antifibrotic agent following trabeculectomy in rabbit eyes. Jpn. J. Ophthalmol. 2009, 53:164-170.
37. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.